CART analysis revealed an increased risk for HNSCC among smokers with low XPD and BRCA2 levels, underlining the significance of BRCA2 and its interaction with tobacco-derived carcinogens in the pathogenesis of HNSCC. The gene discussed is ERCC2; the disease is head and neck squamous cell carcinoma.